SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $8.4 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of $2.83.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $2.88 per share.
The biopharmaceutical company posted revenue of $569,000 in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $176,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
